English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Moomoo AI Jan 27, 2024 07:43

Joincare Pharmaceutical's low P/E ratio is due to its foreca...

Joincare Pharmaceutical's low P/E ratio is due to its forecasted growth being below market average. Investors are paying less for the stock due to limited future growth expectations.
Why Investors Shouldn't Be Surprised By Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Low P/E
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
3519 Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    4949
    Followers
    0
    Following
    11K
    Visitors
    Follow
    Heat List
    US
    SymbolMini ChartPrice
    NVDA
    NVIDIA
    -- 109.670
    TSLA
    Tesla
    -- 263.550
    CRWV
    CoreWeave
    -- 40.000
    GOOG
    Alphabet-C
    -- 156.060
    PLTR
    Palantir
    -- 85.850
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.